Published in Infect Immun on September 01, 1998
Therapeutic enhancement of protective immunity during experimental leishmaniasis. PLoS Negl Trop Dis (2011) 0.78
The regulation of immunity to Leishmania major. Annu Rev Immunol (1995) 8.05
CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med (1994) 2.88
Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev (1991) 2.85
Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. J Immunol (1986) 2.38
Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol (1995) 1.53
Resistance to murine cutaneous leishmaniasis is mediated by TH1 cells, but disease-promoting CD4+ cells are different from TH2 cells. Eur J Immunol (1990) 1.29
IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J Immunol (1993) 1.21
Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol (1991) 1.09
Early IL-4 production does not predict susceptibility to Leishmania major. Exp Parasitol (1996) 1.06
More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes. J Immunol Methods (1987) 0.99
Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines. J Immunol (1987) 0.93
Characterization and use of monoclonal and polyclonal antibodies against the mouse interferon-gamma receptor. J Leukoc Biol (1992) 0.92
Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. Adv Immunol (1996) 0.91
Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4. J Immunol (1993) 0.84
Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. J Immunol (1996) 0.81
Interleukin-1 and interferon-alpha augment interleukin-2 (IL-2) production by distinct mechanisms at the IL-2 mRNA level. Cell Immunol (1994) 0.80
Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med (1993) 5.75
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med (2000) 5.08
High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother (2000) 2.03
Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli. Clin Infect Dis (2002) 2.00
Structure of the SHV-1 beta-lactamase. Biochemistry (1999) 1.87
In vivo production and function of IL-12 p40 homodimers. J Immunol (1997) 1.72
Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun (1994) 1.71
Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol (1995) 1.53
IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J Immunol (1993) 1.21
Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity. Cell Immunol (1998) 1.10
IFN-gamma-independent production of IL-12 during murine endotoxemia. J Immunol (1996) 1.02
Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization. Biochim Biophys Acta (2001) 1.02
Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli. FEMS Microbiol Lett (2001) 0.93
Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody. Infect Immun (1999) 0.89
Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy. J Exp Med (1999) 0.89
Immunoregulation of murine leishmaniasis by interleukin-12. Res Immunol (1996) 0.81
Identification and molecular cloning of a 67-kilodalton protein in Schistosoma japonicum homologous to a family of actin-binding proteins. Infect Immun (1997) 0.80
Cytotoxic and mutagenic effects of the photodynamic action of chloroaluminum phthalocyanine and visible light in L5178Y cells. Photochem Photobiol (1989) 0.77
Fulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient. Transpl Infect Dis (2015) 0.75
'New math' teaches lessons of reducing costs of care. Mod Healthc (1989) 0.75
Sex differences in the perception of touching. Percept Mot Skills (1978) 0.75
Success or survival. Redeploying strategic assets to maximize their value. Health Prog (1991) 0.75
Physical Contact between Mother and Young. Science (1963) 0.75
Act now to maximize Medicare payments for capital. Healthc Financ Manage (1989) 0.75
Leasing equipment minimizes capital investment. Healthc Financ Manage (1989) 0.75
Effects of stress upon social distance in dolphins. Percept Mot Skills (1968) 0.75
Role of sex identification in perception of a social blunder. Percept Mot Skills (1977) 0.75